Latest Announcements

Amerise Biosciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net loss of Rs. 8.14 crores and earnings per share of Rs. 0.01.

Vishnu Chemicals Ltd has announced the audio link of the Analysts/Investors' Conference Call conducted on August 03, 2026, where discussions were on Q1FY27 financial results.

Incredible Industries Ltd has informed the BSE and NSE about the closure of the trading window for its designated persons and their immediate relatives from July 1, 2026, till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The board meeting is scheduled on August 10, 2026, to discuss and approve the unaudited financial results.

Amerise Biosciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net loss of Rs. 8.14 lakhs. The company's revenue from operations was Rs. 7.92 lakhs, and its expenses totaled Rs. 8.14 lakhs. The net loss after tax was Rs. 8.14 lakhs, and the earnings per share was Rs. 0.01.

Wanbury Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30, 2026.

Fabtech Technologies Ltd reported a 10% year-on-year revenue growth and a full turnaround from a loss to a profit in Q1 FY27, despite a challenging global environment. The company's consolidated revenue stood at Rupees 74.98 crore, with a net profit of Rupees 4.21 crores and an EBITDA margin of 9%. The management attributed the turnaround to its geographical mix shifting towards higher value markets and a stellar performance from its Saudi operations.

GPT Healthcare Limited reported unaudited financial results for Q1FY27, with total income at Rs 128 crore, a growth of 18% y-o-y. EBITDA and PAT stood at Rs 26.2 crore and Rs 12.7 crore, respectively. The company maintained a competitive ARPOB and recorded steady improvement in occupancy rates. Key operational highlights included the completion of over 700+ renal transplants, launch of robotic knee surgery programme, and delivery of over 700 radiation therapy procedures.

Platinum Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 to consider and approve the unaudited financial results for the quarter ended on June 30, 2026.

Ganon Products Ltd has announced its unaudited financial results for the first quarter and three months ended on 30th June, 2026, with a net profit of ₹4.25 lakhs and earnings per share of ₹0.05.

Strides Pharma Science Ltd reported Q1 FY27 results, with 13% YoY growth in topline, driven by broad-based contributions across its business, and maintained EBITDA margins at 18.2% despite additional operating and freight costs.

Dr Agarwals Eye Hospital Ltd-$ announced the outcome of its Board Meeting held on August 03, 2026, where it considered and approved unaudited financial results for the quarter ended June 30, 2026, along with the re-appointment of Cost Auditors for the financial year 2026-27.

Foseco Crucible (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the dissolution of its Risk Management Committee. The company's board of directors has considered and approved the unaudited financial results, which are enclosed with the announcement. The company has also provided a limited review report from its statutory auditor, Deloitte Haskins & Sells LLP.

Nucleus Software Exports Ltd announced its Q2 FY2026-27 earnings, with revenue at INR 210.4 crore, a 6.4% QoQ and 3.4% YoY growth. The company's EBITDA was INR 7.6 crore, with margins at 3.6%. The company also announced the launch of its new GA, FinnAxia, and the appointment of Bhavit Godiwala as Chief Customer Success Officer.

Avadh Sugar & Energy Ltd has released an investor presentation for Q1FY27, highlighting its financial highlights and sustainability initiatives.

Thomas Cook (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at their meeting held on August 3, 2026. The results will be published in newspapers as prescribed.

Chadha Papers Ltd has scheduled a board meeting on August 11, 2026, to consider partial redemption of 0.01% redeemable non-convertible, non-cumulative preference shares. The trading window for dealing in shares of the company will remain closed till two days from the declaration of unaudited financial results for the quarter ended August 14, 2026.

Amerise Biosciences Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company's revenue from operations was Rs. 7.92 lakhs, with a profit before tax of Rs. (8.14) lakhs. The net loss after tax was Rs. (8.14) lakhs. The company's earnings per share (EPS) was (0.01) for the quarter.

Sicagen India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 to consider and approve the Un-audited Financial Results for the Quarter ended 30th June, 2026.

Incredible Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve the unaudited financial results for the quarter ended 30 June, 2026.

Concord Drugs Ltd has scheduled a board meeting on 10/08/2026 to consider and approve the un-audited financial results for the quarter ended 30/06/2026.